Amphastar Pharmaceuticals Operating Expenses 2012-2024 | AMPH
Amphastar Pharmaceuticals operating expenses from 2012 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Amphastar Pharmaceuticals Annual Operating Expenses
(Millions of US $) |
| 2023 |
$447 |
| 2022 |
$391 |
| 2021 |
$368 |
| 2020 |
$339 |
| 2019 |
$322 |
| 2018 |
$303 |
| 2017 |
$241 |
| 2016 |
$240 |
| 2015 |
$258 |
| 2014 |
$228 |
| 2013 |
$212 |
| 2012 |
$179 |
| 2011 |
$152 |
| 2009 |
$49 |
Amphastar Pharmaceuticals Quarterly Operating Expenses
(Millions of US $) |
| 2024-06-30 |
$127 |
| 2024-03-31 |
$124 |
| 2023-12-31 |
$124 |
| 2023-09-30 |
$108 |
| 2023-06-30 |
$109 |
| 2023-03-31 |
$107 |
| 2022-12-31 |
$97 |
| 2022-09-30 |
$97 |
| 2022-06-30 |
$99 |
| 2022-03-31 |
$99 |
| 2021-12-31 |
$97 |
| 2021-09-30 |
$87 |
| 2021-06-30 |
$91 |
| 2021-03-31 |
$93 |
| 2020-12-31 |
$93 |
| 2020-09-30 |
$80 |
| 2020-06-30 |
$89 |
| 2020-03-31 |
$77 |
| 2019-12-31 |
$84 |
| 2019-09-30 |
$78 |
| 2019-06-30 |
$78 |
| 2019-03-31 |
$83 |
| 2018-12-31 |
$88 |
| 2018-09-30 |
$73 |
| 2018-06-30 |
$74 |
| 2018-03-31 |
$68 |
| 2017-12-31 |
$62 |
| 2017-09-30 |
$61 |
| 2017-06-30 |
$63 |
| 2017-03-31 |
$55 |
| 2016-12-31 |
$68 |
| 2016-09-30 |
$58 |
| 2016-06-30 |
$58 |
| 2016-03-31 |
$55 |
| 2015-12-31 |
$63 |
| 2015-09-30 |
$68 |
| 2015-06-30 |
$64 |
| 2015-03-31 |
$64 |
| 2014-12-31 |
$63 |
| 2014-09-30 |
$68 |
| 2014-06-30 |
$50 |
| 2014-03-31 |
$48 |
| 2013-12-31 |
$52 |
| 2013-09-30 |
$59 |
| 2013-06-30 |
$51 |
| 2013-03-31 |
$51 |
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.438B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
